"Citrix is dedicated to producing high-quality products that meet the highest standards of safety and performance. This quality policy reflects our commitment to excellence and continuous improvement." Citrix is committed to manufacturing and supplying high-quality pharmaceutical products that meet or exceed regulatory requirements, customer expectations, and international standards. We strive for continuous improvement, innovation, and excellence in every aspect of our operations.
Ensuring the quality of Active Pharmaceutical Ingredients is crucial for the safety and efficacy of pharmaceuticals. By adhering to regulatory standards, implementing robust quality control measures by Conduct thorough testing of raw materials before use. Our dedicated team works to Source high-quality raw materials with complies with GMP regulations and pharmacopoeias.
Sourcing high-quality raw materials from reputable suppliers is crucial for ensuring the quality of Active Pharmaceutical Ingredients (APIs). We considerations for effective sourcing like Research potential suppliers’ backgrounds, including their industry reputation and history of compliance with quality standards. Verify that suppliers hold relevant certifications, such as GMP, ISO 9001 and ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients) or other industry-specific credentials.
Foster a culture of continuous improvement through regular training, audits, and process evaluations. Implement a corrective and preventive action (CAPA) system to address any quality issues. Stay updated on regulations from agencies like the FDA, EMA, and others regarding API quality. Ensure that all quality systems are compliant with relevant regulatory requirements. Adopt a QbD approach to enhance the quality of APIs by integrating quality considerations into the development process.
Maintain a robust system for tracking the origin and batch history of raw materials to ensure traceability.